NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Anderson, David J ^a   Kaplan, David I ^b   Bell, Katrina M ^a   Koutsis, Katerina ^a   Haynes, John M ^c   Mills, Richard J ^d   Phelan, Dean G ^a   Qian, Elizabeth L ^a   Leitoguinho, Ana Rita ^a   Arasaratnam, Deevina ^a   Labonne, Tanya ^a   Ng, Elizabeth S ^a   Davis, Richard P ^e   Casini, Simona ^e   Passier, Robert ^e   Hudson, James E ^d   Porrello, Enzo R ^d   Costa, Mauro W ^f   Rafii, Arash ^g,h   Curl, Clare L ^b   Delbridge, Lea M ^b   Harvey, Richard P ^i,j   Oshlack, Alicia ^a   Cheung, Michael M ^a,b   Mummery, Christine L ^e   Petrou, Stephen ^b   Elefanty, Andrew G ^a,b,c   Stanley, Edouard G ^a,b,c   Elliott, David A ^a,b,c   more..

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f JACKSON LABORATORY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HOMEOBOX PROTEIN NKX-2.5; VASCULAR CELL ADHESION MOLECULE 1; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HEY2 PROTEIN, HUMAN; NKX2-5 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; REPRESSOR PROTEIN;

BIOMARKER; CARDIOVASCULAR DISEASE; CELL; EXPERIMENTAL STUDY; GENETIC ANALYSIS; GENETIC ENGINEERING; MUTATION; PROTEIN;

ARTICLE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL DIFFERENTIATION; CONGENITAL HEART DISEASE; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENE REGULATORY NETWORK; HEART DEVELOPMENT; HUMAN; HUMAN EMBRYONIC STEM CELL; MUSCLE DEVELOPMENT; ACTION POTENTIAL; CELL LINE; CYTOLOGY; DEFICIENCY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; ORGANOGENESIS; PATCH CLAMP TECHNIQUE; PHYSIOLOGY;

ACTION POTENTIALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HOMEOBOX PROTEIN NKX-2.5; HUMAN EMBRYONIC STEM CELLS; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGANOGENESIS; PATCH-CLAMP TECHNIQUES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85045308111     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03714-x     Document Type: Article

References (70)

1. Kathiriya, I. S., Nora, E. P. & Bruneau, B. G. Investigating the transcriptional control of cardiovascular development. Circ. Res. 116, 700-714 (2015).
2. Davidson, E. H. & Erwin, D. H. Gene regulatory networks and the evolution of animal body plans. Science 311, 796-800 (2006).
3. Garg, V. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443-447 (2003).
4. Li, Q. Y. et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet 15, 21-29 (1997).
5. Schott, J. J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111 (1998).
6. Elliott D., Kirk E., Schaft D. & Harvey, R. in Heart Development and RegenerationVol. 2 (eds Rosenthal, N. & Harvey, R. P.) Ch 1.1 (Academic Press, 2010).
7. Prall, O. W. J. et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128, 947-959 (2007).
8. Lyons, I. et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 9, 1654-1666 (1995).
9. Li, G. et al. Transcriptomic profiling maps anatomically patterned subpopulations among single embryonic cardiac cells. Dev. Cell 39, 491-507 (2016).
10. Chowdhury, R. et al. Mouse model of human congenital heart disease: progressive atrioventricular block induced by a heterozygous Nkx2-5 homeodomain missense mutation. Circ. Arrhythm. Electrophysiol. 8, 1255-1264 (2015).
11. Ashraf, H. et al. A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation. Circ. Cardiovasc Genet 7, 423-433 (2014).
12. Bouveret, R. et al. NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets. eLife, e06942 (2015).
13. Risebro, C. A. et al. Epistatic rescue of Nkx2.5 adult cardiac conduction disease phenotypes by prospero-related homeobox protein 1 and HDAC3. Circ. Res 111, 19-31 (2012).
14. Luna-Zurita, L. et al. Complex interdependence regulates heterotypic transcription factor distribution and coordinates cardiogenesis. Cell 164, 999-1014 (2016).
15. Weber, D., Wiese, C. & Gessler, M. Hey bHLH transcription factors. Curr. Top. Dev. Biol. 110, 285-315 (2014).
16. Elliott, D. A. et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8, 1037-1040 (2011).
17. Clark, C. D. et al. Evolutionary conservation of Nkx2.5 autoregulation in the second heart field. Dev. Biol. 374, 198-209 (2013).
18. Skelton, R. J. et al. SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res 13, 172-179 (2014).
19. Devalla, H. D. et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7, 394-410 (2015).
20. Birket, M. J. et al. Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells. Nat. Biotechnol. 33, 970-979 (2015).
21. Protze, S. I. et al. Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker. Nat. Biotechnol. 35, 56-68 (2017).
22. Raynaud, C. M. et al. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS ONE 8, e54524 (2013).
23. Bloomekatz, J. et al. Platelet-derived growth factor (PDGF) signaling directs cardiomyocyte movement toward the midline during heart tube assembly. eLife 6, e21172 (2017).
24. Li, G., Plonowska, K., Kuppusamy, R., Sturzu, A. & Wu, S. M. Identification of cardiovascular lineage descendants at single-cell resolution. Development 142, 846-857 (2015).
25. Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372-E8381 (2017).
26. Paige, S. L. et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 151, 221-232 (2012).
27. Bruneau, B. G. et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev. Biol. 217, 266-277 (2000).
28. Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl Acad. Sci. USA 109, E1848-E1857 (2012).
29. Warren, S. A. et al. Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart. Mol. Cell Biol. 31, 4633-4645 (2011).
30. Satin, J. et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. 559, 479-496 (2004).
31. Jones, D. K. et al. hERG 1b is critical for human cardiac repolarization. Proc. Natl Acad. Sci. USA 111, 18073-18077 (2014).
32. Furtado, M. B. et al. A novel conditional mouse model for Nkx2-5 reveals transcriptional regulation of cardiac ion channels. Differentiation 91, 29-41 (2016).
33. Lübkemeier, I. et al. Human Connexin43E42K mutation from a sudden infant death victim leads to impaired ventricular activation and neonatal death in mice. Circ. Cardiovasc. Genet. 8, 21-29 (2015).
34. Lescroart, F. et al. Early lineage restriction in temporally distinct populations of Mesp1 progenitors during mammalian heart development. Nat. Cell Biol. 16, 829-840 (2014).
35. Dorn, T. et al. Direct Nkx2-5 transcriptional repression of Isl1 controls cardiomyocyte subtype identity. Stem Cells 33, 1113-1129 (2014).
36. Lizio, M. et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 16, 22 (2015).
37. Arndt, A. K. et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am. J. Hum. Genet. 93, 67-77 (2013).
38. Harmelink, C. et al. Myocardial Mycn is essential for mouse ventricular wall morphogenesis. Dev. Biol. 373, 53-63 (2013).
39. Kim, K. H., Rosen, A., Bruneau, B. G., Hui, C. C. & Backx, P. H. Iroquois homeodomain transcription factors in heart development and function. Circ. Res. 110, 1513-1524 (2012).
40. Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N. & Izumo, S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126, 1269-1280 (1999).
41. Bruneau, B. G. et al. Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol. Cell Biol. 21, 1730-1736 (2001).
42. Bao, Z.-Z., Bruneau, B., Seidman, J. G., Seidman, C. E. & Cepko, C. Regulation of chamber-specific gene expression in the developing heart by Irx4. Science 283, 1161-1164 (1999).
43. Koibuchi, N. & Chin, M. T. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circ. Res. 100, 850-855 (2007).
44. Xin, M. et al. Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc. Natl Acad. Sci. USA 104, 7975-7980 (2007).
45. Kokubo, H., Tomita-Miyagawa, S., Hamada, Y. & Saga, Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 134, 747-755 (2007).
46. Wu, S.-P. et al. Atrial identity is determined by a COUP-TFII regulatory network. Dev. Cell 25, 417-426 (2013).
47. Hartman, M. E. et al. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias. FASEB J. 28, 3007-3015 (2014).
48. D'Amato, G., Luxan, G. & de la Pompa, J. L. Notch signalling in ventricular chamber development and cardiomyopathy. FEBS J. 283, 4223-4237 (2016).
49. Stennard, F. A. et al. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev. Biol. 262, 206-224 (2003).
50. Kao, T. et al. GAPTrap: a simple expression system for pluripotent stem cells and their derivatives. Stem Cell Rep. 7, 518-526 (2016).
51. Liu, H., Harris, T. M., Kim, H. H. & Childs, G. Cardiac myocyte differentiation: the Nkx2.5 and Cripto target genes in P19 clone 6 cells. Funct. Integr. Genom. 5, 218-239 (2005).
52. Uosaki, H. et al. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS ONE 6, e23657 (2011).
53. Yang, J. T., Rayburn, H. & Hynes, R. O. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121, 549-560 (1995).
54. Kwee, L. et al. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121, 489-503 (1995).
55. DeLaughter, D. M. et al. Single-cell resolution of temporal gene expression during heart development. Dev. Cell 39, 480-490 (2016).
56. Donovan, J., Kordylewska, A., Jan, Y. N. & Utset, M. F. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 12, 1605-1610 (2002).
57. Gessler, M. et al. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr. Biol. 12, 1601-1604 (2002).
58. Bezzina, C. R. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 45, 1044-1049 (2013).
59. Verweij, N. et al. Twenty-eight genetic loci associated with ST-T-wave amplitudes of the electrocardiogram. Hum. Mol. Genet. 25, 2093-2103 (2016).
60. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
61. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
62. Davis, R. P. et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat. Protoc. 3, 1550-1558 (2008).
63. Richards, M., Fong, C. Y., Chan, W. K., Wong, P. C. & Bongso, A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936 (2002).
64. Skelton, R. J. et al. CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells. Stem Cell Rep. 6, 95-108 (2016).
65. Watmuff, B. et al. Human pluripotent stem cell derived midbrain PITX3 (eGFP/w) neurons: a versatile tool for pharmacological screening and neurodegenerative modeling. Front Cell Neurosci. 9, 104 (2015).
66. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
67. Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
68. Ritchie, M. E. et al. limma powers differential expression analyses for RNAsequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
69. Southan, C. et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: Towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 44, D1054-D1068 (2016).
70. Wang, Z., Wang, D.-Z., Pipes, G. C. T. & Olson, E. N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl Acad. Sci. USA 100, 7129-7134 (2003).